𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quinazoline antifolates inhibiting thymidylate synthase. Variation of the amino acid

✍ Scribed by Jones, Terence R.; Smithers, Michael J.; Betteridge, Richard F.; Taylor, Michael A.; Jackman, Ann L.; Calvert, A. Hilary; Davies, Lawrence C.; Harrap, Kenneth R.


Book ID
126035569
Publisher
American Chemical Society
Year
1986
Tongue
English
Weight
692 KB
Volume
29
Category
Article
ISSN
0022-2623

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The synthesis of novel nonclassical reve
✍ Aleem Gangjee; Mohit KotharΓ©; Roy L. Kisliuk πŸ“‚ Article πŸ“… 2000 πŸ› Journal of Heterocyclic Chemistry 🌐 English βš– 427 KB

## Abstract 2‐Amino‐6‐methyl‐5‐(pyridin‐4‐ylsulfanyl)‐3__H__‐quinazolin‐4‐one (**3**, AG337) a lipophilic thymidylate synthase inhibitor, is currently in clinical trials as an antitumor agent. On the basis of the crystal structure of **3** and the classical inhibitor 10‐propargyl‐5,8‐dideazafolic a

Cell cycle effects of CB30865, a lipophi
✍ L. A. Skelton; M. G. Ormerod; J. C. Titley; A. L. Jackman πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 251 KB πŸ‘ 1 views

CB30865 (p-[N-(7-bromo-3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl+ ++)-N-(prop-2-ynyl)amino]-N-(3-pyridylmethyl)benzamide) is a quinazoline-based pyridine-containing compound that emerged from a programme aimed at the development of thymidylate synthase (TS) inhibitors as anticancer agents. Its